Illumina, Inc. (ILMN): EBITDA
$1.08B
Year ended 2025-12-28
+7.0%
5-year compound annual growth
+3.8%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $1.08B | n/m | 2026-02-12, From 2024-12-30 |
| 2024-12-29 | -$479.00M | n/m | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | -$637.00M | n/m | 2026-02-12, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | -$3.79B | n/m | 2025-02-12, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $128.00M | -83.3% | 2024-02-16, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $767.00M | -34.6% | 2023-02-17, From 2019-12-30 |
| 2019-12-29 | $1.17B | +10.5% | 2022-02-18, From 2018-12-31 |
| 2018-12-30 | $1.06B | +39.4% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $762.00M | +4.7% | 2020-02-11, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $728.00M | -1.6% | 2019-02-12, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $740.00M | +18.0% | 2018-02-13, From 2014-12-29 |
| 2014-12-28 | $627.28M | n/a | 2017-02-14, From 2013-12-30 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Illumina, Inc. (ILMN) | 2025-12-28 | $1.08B | n/m |
| Bruker Corp (BRKR) | 2025-12-31 | $288.50M | -34.0% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $164.00M | -89.0% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $761.98M | -1.6% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $1.77B | +1.3% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $212.60M | -49.5% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | -$24.79M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$32.80M | n/m |
| Quanterix Corp (QTRX) | 2025-12-31 | -$109.70M | n/m |
Compare ILMN, BRKR, AVTR, RVTY side by side · Screen every company in Laboratory Analytical Instruments ↗